Tenderwize
Wróć do wyszukiwania

Open-house biologics rebate agreement for Teriparatide

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 29, 2028 · 613 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-06 - Teriparatid

61/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

61 / 100

Złożoność

56 / 100

Czynniki ryzyka

The structured data gives a deadline of 2028-04-29 21:59:59 UTC, while the XML text also mentions 2028-04-30 as an end...

The notice says offers/contracts cannot be submitted via the portal; submission must be by email with qualified electro...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Conclusion of rebate agreements for the active substance Teriparatid.
  • Supply arrangement for pharmaceutical products under an open-house model.
Pokaż pełne podsumowanie

Open-house supply arrangement for pharmaceutical products (Teriparatid) led by Techniker Krankenkasse with HEK and hkk as participating buyers. The procedure is non-exclusive, with no individual negotiations and uniform conditions for all suitable pharmaceutical undertakings. The contract term is up to 24 months from 01.05.2026 and ends no later than 30.04.2028. Documents are available online, but only the XML/tender text was provided here, so procurement documents were not fully analyzed.

Ryzyka

The structured data gives a deadline of 2028-04-29 21:59:59 UTC, while the XML text also mentions 2028-04-30 as an end...

The notice says offers/contracts cannot be submitted via the portal; submission must be by email with qualified electro...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • The bidder must be a pharmaceutical undertaking within the meaning of § 4(18) AMG for the offered medicinal products.
  • The bidder must have its seat in the AMG territory, another EU Member State, or an EEA state.
  • A valid marketing authorization for the contract medicinal product(s) is required, or another legal basis to place the product on the market in its own name.

Kryteria udzielenia

Lot 1

No explicit award criteria provided; open-house uniform conditions only.

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (1)

LOT-0001

Open-house biologics rebate agreement for Teriparatide

Supply contract for Teriparatid under an open-house procedure. Scope is nationwide in Germany. The arrangement is non-exclusive and open to all eligible pharmaceutical undertakings during the contract period.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Apr 2026 - Apr 2028

Kategoria

Pharmaceutical products

Kryteria udzielenia

No explicit award criteria provided; open-house uniform conditions only.

Termin

Deadline Apr 29, 2028

Szczegóły zamówienia

Data publikacji
15 Mar 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
179543-2026

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3